Patent | Date |
---|
Novel Monoclonal Antibodies To Osteopontin App 20190367602 - MCKEARN; John P. ;   et al. | 2019-12-05 |
Methods For The Modulation Of Crp By The Selective Modulation Of Ppar Delta App 20080004281 - Rao; Tadimeti S. ;   et al. | 2008-01-03 |
Combination therapy including a matrix metalloproteinase inhibitor and an antineoplastic agent Grant 6,916,800 - McKearn , et al. July 12, 2 | 2005-07-12 |
Methods of ex-vivo expansion of hematopoeitic cells using multivariant IL-3 hematopoiesis chimera proteins App 20050059149 - Bauer, S. Christopher ;   et al. | 2005-03-17 |
Combination therapy including a matrix metalloproteinase inhibitor and an antineoplastic agent App 20050058725 - McKearn, John P. ;   et al. | 2005-03-17 |
Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia Grant 6,858,598 - McKearn , et al. February 22, 2 | 2005-02-22 |
Combination therapy including a cyclooxygenase-2 inhibitor and an antineoplastic agent App 20050037090 - McKearn, John P. ;   et al. | 2005-02-17 |
Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia Grant 6,833,373 - McKearn , et al. December 21, 2 | 2004-12-21 |
Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia App 20040234624 - McKearn, John P. ;   et al. | 2004-11-25 |
Multi-functional hematopoietic fusion proteins between sequence rearranged G-CSF receptor agonists and other hematopoietic factors App 20040171115 - Feng, Yiqing ;   et al. | 2004-09-02 |
Circular permuteins of flt3 ligand App 20040127410 - McWherter, Charles A. ;   et al. | 2004-07-01 |
Fused G-CSF and IL-3 proteins and uses thereof Grant 6,730,303 - Feng , et al. May 4, 2 | 2004-05-04 |
Method of using an integrin antagonist and radiation therapy as combination therapy in the treatment of neoplasia Grant 6,689,787 - McKearn , et al. February 10, 2 | 2004-02-10 |
Combination therapy of radiation and a COX-2 inhibitor for treatment of neoplasia Grant 6,649,645 - McKearn , et al. November 18, 2 | 2003-11-18 |
Co-administration of interleukin-3 mutant polypeptides with CSF's for multi-lineage hematopoietic cell production App 20030194783 - McKearn, John P. ;   et al. | 2003-10-16 |
Methods of ex-vivo expansion of hematopoeitic cells using multivariant IL-3 hematopoiesis chimera proteins App 20030185790 - Bauer, S. Christopher ;   et al. | 2003-10-02 |
Methods of ex-vivo expansion of hematopoeitic cells using interleukin-3 mutant polypeptides with other hematopoietic growth factors App 20030165461 - Bauer, S. Christopher ;   et al. | 2003-09-04 |
Method of ex-vivo expansion of hematopoeitic cells using interleukin-3 (IL-3) multiple mutation polypeptides App 20030103936 - Bauer, S. Christopher ;   et al. | 2003-06-05 |
Antiangiogenic combination therapy for the treatment of cancer App 20020103141 - McKearn, John P. ;   et al. | 2002-08-01 |
Methods of using multivariant IL-3 hematopoiesis fusion protein Grant 6,361,977 - Bauer , et al. March 26, 2 | 2002-03-26 |
Phenylacetonitrilealkylaminoalkyl-ortho-substituted aryl compounds as immunosuppressives App 20010016602 - Liang, Chi-Dean ;   et al. | 2001-08-23 |
Halogenated phenylacetonitrile alkylaminoalkylphenyl compounds as immunosuppressives Grant 6,265,439 - Mueller , et al. July 24, 2 | 2001-07-24 |
G-CSF receptor agonists Grant 6,100,070 - Zurfluh , et al. August 8, 2 | 2000-08-08 |
Co-administration of interleukin-3 mutant polypeptides with CSF's for multi-lineage hematopoietic cell production Grant 6,093,395 - Bauer , et al. July 25, 2 | 2000-07-25 |
Multi-functional hematopoietic fusion proteins between sequence rearranged C-MPL receptor agonists and other hematopoietic factors Grant 6,066,318 - Feng , et al. May 23, 2 | 2000-05-23 |
Fusion proteins comprising multiply mutated interleukin-3 (IL-3) polypeptides and second growth factors Grant 6,030,812 - Bauer , et al. February 29, 2 | 2000-02-29 |
Treatment of hematopoietic disorders with fusion proteins comprising multiply mutated interleukin-3 (IL-3) polypeptides and second growth factors Grant 6,022,535 - Bauer , et al. February 8, 2 | 2000-02-08 |
Interleukin-3 (IL-3) variant fusion proteins, their recombinant production, and therapeutic compositions comprising them Grant 5,738,849 - Bauer , et al. * April 14, 1 | 1998-04-14 |
Interleuken-3 (IL-3) human/murine hybrid polypeptides and recombinant production of the same Grant 5,501,962 - Braford-Goldberg , et al. March 26, 1 | 1996-03-26 |
Method of using phenylacetonitrilealkylaminoalkyl-ortho-substituted aryl compounds as immunosuppressives Grant 5,486,539 - Liang , et al. January 23, 1 | 1996-01-23 |
Halogenated phenylacetonitrile alkylaminoalkylphenyl compounds as immunosuppressives Grant 5,451,604 - Mueller , et al. September 19, 1 | 1995-09-19 |
Phenylacetonitrilehydroxyalkylaminoalkyl-ortho-substituted aryl compounds as immunosuppressives Grant 5,247,119 - Fowler , et al. September 21, 1 | 1993-09-21 |
Phenylacetonitrilealkylaminoalkyl-ortho-substituted aryl compounds as immunosuppressives Grant 5,162,569 - Liang , et al. November 10, 1 | 1992-11-10 |